ABSTRACT. As an index of iron absorption, erythrocyte incorporation of the stable isotope, 58Fe, was determined 14 and 42 d after the administration of 58Fe-labeled ferrous sulfate to 56-d-old exclusively breast-fed infants and to infants fed a low-iron (1.8 mg/L) formula. Each infant received a dose of 0.6 to 1.0 mg of iron with ascorbic acid between feedings on each of 3 consecutive d. Fourteen d after administration of the 58Fe-labeled iron doses (age 70 d), arithmetic mean incorporation of the 58Fe label into erythrocytes by breast-fed infants was 20.0% of the doseonly slightly less than that reported for erythrocyte incorporation of iron by fasting adults fed small quantities of 59Fe-labeled human milk. Erythrocyte incorporation of iron by the formula-fed infants was 6.9% of the dose, suggesting that, even between feedings, components of infant formula exerted a major inhibitory effect on iron absorption. For reasons that are not clear, the percentage of the administered label incorporated into erythrocytes was significantly greater in breast-fed (but not in formula-fed infants) at 112 d of age than at 70 d of age. (Pediatr Res 33: 573-576, 1993) Abbreviations MIR58/57, mass isotope ratio 58Fe/57Fe
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The body iron content at term birth of most infants is sufficient to support hematopoiesis until about 4 mo of age. Administration of iron before 4 mo of age might enhance iron stores and therefore decrease the quantity of absorbed iron required subsequently. Few physicians recommend iron supplements for breastfed infants during the early months of life, and many physicians prefer low-iron formulas to "iron-fortified formulas," at least during the early months of life. The reasons that many physicians prefer to avoid iron supplementation during early infancy are poorly defined. Fear of adverse reactions is often cited, but two studies have failed to demonstrate a relation between iron administration and adverse reactions (1, 2).
If the extent of iron absorption is seriously limited during the early months of life, there would be little point in recommending use of iron supplements or iron-fortified formulas until an age at which iron could be shown to be reasonably well absorbed. The extent of iron absorption during the first few months of life is therefore an important bit of information that enters into the recommendation about iron supplementation of infants.
To obtain such information, we have determined the extent of erythrocyte incorporation of the stable isotope, 58Fe, administered between feedings to normal 56-d-old breast-fed and formula-fed infants. Although the quantity of administered iron promptly (i.e. within 2 wk) incorporated into erythrocytes is generally somewhat less than the amount absorbed, incorporation of an iron isotope into erythrocytes has been widely used as a index of the extent of iron absorption by adults and by term (3-6) and preterm (7, 8) infants.
SUBJECTS AND METHODS
The protocol for the study was reviewed and approved by the University of Iowa Committee on Research Involving Human Subjects. Informed consent was obtained from at least one parent of each infant.
Subjects, feedings, and administration of 58Fe-enriched ferrous sulfate. Fourteen normal term breast-fed infants (seven males and seven females) and 20 formula-fed infants (10 males and 10 females), were studied. Gestational ages were 38 wk or more, and birth weights were 2685 to 4055 g. The infants were enrolled at 6 to 9 d of age, and until at least 62 d of age were either exclusively breast-fed with a daily supplement of vitamins A, C, and D and fluoride (Mead Johnson Nutritionals, Evansville, IN) or were fed a milk-based formula (Similac, Ross Laboratories) with a low iron concentration. The formula was from a single lot. Concentration of iron was determined by atomic absorption spectrophotometry in duplicate with three cans of formula from different cases. Concentrations ranged from 1.8 to 1.9 mg/L with a mean value of 1.8 mg/L. For 3 consecutive d beginning at 56 d of age ( f 4 d), each infant visited the Lora N. Thomas Pediatric Metabolic Unit of the University of Iowa and was given a dose of '*Fe-enriched ferrous sulfate. Formula-fed infants were more readily recruited for the study than were breast-fed infants, and all of the formulafed infants were given the test doses from the same batch of 58Fe-enriched ferrous sulfate, providing 0.5 mg of "Fe in a total of 0.6 mg of iron in each test dose. Some of the breast-fed infants were given iron from this batch, whereas other breast-fed infants were given iron from other batches in which the '*Fe enrichment was different. The breast-fed infants received 0.5 to 0.6 mg of "Fe and a total quantity of iron in each test dose of 0.6 to 1.0 mg.
For all the infants, each dose consisted of a solution of 5uFe-enriched ferrous sulfate in 1.9 mL of a 10% solution of glucose in water with 10 mg of ascorbic acid. The solution was drawn up into a 5-mL syringe, weighed, and delivered from the syringe directly into the infant's mouth. This dose was followed immediately by two 5-mL rinses of the syringe with a 5% solution of glucose in water delivered from the syringe directly into the infant's mouth. The dose of iron was given between 0900 and 1300 h. Feedings were not permitted for 2 h before or for 1 h after ingestion of the iron dose. The infants were closely observed to detect regurgitation during the hour after ingestion of the dose.
At approximately 62 d of age (i.e. 4 d after the third test dose of iron had been administered), the parents of the breast-fed infants were instructed to give a daily supplement of 7.5 mg of iron in the form of ferrous sulfate (Fer-in-Sol, Mead Johnson, Evansville, IN) and were permitted to feed iron-fortified formula (Similac with Iron, Ross Laboratories) as a supplement to breast feeding. No effort was made to ensure compliance with the instructions to give the daily supplement of iron. At approximately 62 d of age, the low-iron formula previously fed to the formula-fed infants was changed to an iron-fortified formula (Similac with Iron), providing 12 mg of iron/L (label claim) in the form of ferrous sulfate. Women who elected to discontinue breast feeding fed their infants the iron-fortified formula.
Laboratory analyses. Venous or capillary blood was obtained at ages 56, 70, and 112 d of age (*4 d). The sample at 56 d of age was obtained before administration of the first of the three doses of j8Fe. Blood was analyzed for Hb concentration by Coulter Counter, model M430 (Coulter Electronics, Inc., Hialeah, FL), for femtin concentration by RIA using the Rainen Ferritin ['251] RIA Kit, (catalog no. NEA-078, E.I. DuPont de Nemours and Co., New England Nuclear Research Products, Boston, MA), and for the mass isotope ratio, 58Fe/57Fe (MIR58/j7), by inductively coupled plasma mass spectrometry as described previously (9) .
Calculations. The quantity of 58Fe label incorporated into erythrocytes at ages 70 and 112 d was calculated as described previously (6) . Statistical analyses were performed using SAS version 5.18 (SAS Institute Inc., Cary, NC).
RESULTS
No infant was observed to regurgitate during the hour after administration of the test dose of 58Fe. Data on body weight, Hb concentration, serum ferntin concentration, and MIR581j7 are presented for ages 56, 70, and 1 12 d in Table 1 . Also included in the table is the percentage of the administered j8Fe label that was incorporated into erythrocytes at 70 and 1 12 d of age.
Hb concentrations were in the anticipated range for infants from 2 to 4 mo of age. Serum concentrations of femtin of most of the infants were relatively high, as has been observed previously (5, 10).
As calculated from the increase in MIR581j7 in blood, the arithmetic mean incorporation into erythrocytes of the 58Fe label in breast-fed infants was 20.0% of the dose at 70 d of age and 22.7% of the dose at 112 d of age (geometric means, 16.0 and 19.1%, respectively). In the 12 infants for whom a value for M1R58/j7 was obtained both at 70 d and at 112 d of age, the difference in incorporation at 70 and 1 12 d of age was significant (paired t test, p < 0.001).
The arithmetic mean incorporation into erythrocytes of the j8Fe label in formula-fed infants was 6.9% of the dose at 70 d of age and 6.9% of the dose at 112 d of age (geometric means, 6.0 and 6.3%, respectively). Whether calculated for 70 d or for 112 d of age, incorporation of the 58Fe tag into erythrocytes was significantly less for formula-fed infants than for breast-fed in-
The difference in erythrocyte incorporation of the 58Fe label was also examined in relation to the serum concentration of ferritin. As was to be anticipated with infants from 56 to 112 d of age, many of the serum concentrations of femtin were quite high. The geometric mean serum ferritin concentration at 56 d of age was 152 pg/L in the breast-fed infants and 125 pg/L in the formula-fed infants. The difference was not significant ( t test, p = 0.58). Corresponding concentrations at 70 d of age were 187 and 143 pg/L ( t test, p = 0.45). Serum concentrations of ferritin were determined in 3 1 of the 36 infants at 56 and/or 70 d of age. Based on the concentration of fenitin at 56 or 70 d of age or the mean of the two values when both were available, the relation between percentage of incorporation of the 58Fe label into erythrocytes at 70 d of age was inversely correlated with serum femtin concentration (partial correlation analysis adjusted for type of feeding, r = -0.6 1, p < 0.001). Significant inverse correlation of serum fenitin and erythrocyte incorporation of iron was also observed in our previous studies of 126-(5) and 154-d-old (6) infants.
The difference in incorporation of the 58Fe label at 70 and 1 12 d of age was significantly greater by breast-fed than by formulafed infants (analysis of covariance with serum femtin concentration as the covariate, p < 0.00 1).
DISCUSSION
When a quite small dose of iron (0.6 to 1.0 mg) accompanied by a relatively large dose of an enhancer of iron absorption (10 mg of ascorbic acid) was administered between feedings to 56-dold, exclusively breast-fed infants, arithmetic mean incorporation of the j8Fe label into erythrocytes 14 d after administration of the iron label was 20.0% of the dose (geometric mean 16.0%). The arithmetic mean value for erythrocyte incorporation of the stable iron isotope by 56-d-old breast-fed infants may be compared with results obtained with fasting adult subjects given small quantities of human milk (86 to 100 mL) tagged with the radioisotope, 5yFe. In three studies, arithmetic mean values for erythrocyte incorporation of the radioisotope were 20.8% of intake for 10 subjects (1 l), 15.4% of intake for eight subjects (12) , and 23.7% of intake for five subjects (13) .
In normal adults, a high percentage of an orally administered iron isotope is promptly incorporated into erythrocytes (l4), and it is generally assumed that 80% or more of absorbed iron is incorporated into erythrocytes within 14 d (15) . The percentage of absorbed iron promptly incorporated into erythrocytes is probably less in 56-d-old infants than in adults. Garby et al. (16) administered 5yFe i.v. to infants of various ages. Incorporation of the 5yFe label into erythrocytes 12 to 14 d after administration of the radioiron was Cjudging from graphic data) 30 to 50% of the dose for three infants 25 to 33 d of age, 65% for an infant 65 d of age, 85% for three infants from 8 1 to 129 d of age, and 70 to 90% for three infants from 223 to 273 d of age. If, in our study, incorporation of iron into Hb was 65% of the amount absorbed, arithmetic mean absorption (calculated from the MIR58157 at 70 d of age) was 30.8% of the dose by the breast-fed infants and 10.6% of the dose by the formula-fed infants.
Previous studies of the erythrocyte incorporation of an iron isotope by breast-fed infants have not been reported. However, by whole-body counting for the radioisotope, 5yFe, 2 wk after its oral administration, data on absorption of iron from human milk has been studied in 5.9-to 7.3-mo-old breast-fed infants (17) and in adult subjects fed human milk (18) . In breast-fed infants (l7), arithmetic mean absorption of iron was 38.1 % of the dose when the tracer was given with a feeding and 48.8% of the dose when the tracer was given 3 h after a feeding. Thus, results obtained by whole-body counting after administration of small doses of 5yFe iron to 6-to 7-mo-old breast-fed infants are in quite good agreement with results obtained by determining erythrocyte incorporation of j8Fe by 2-mo-old breast-fed infants.
When fasting adult subjects were fed 200 mL of human milk labeled with 5yFe, mean absorption of iron was 37.3% of intake by four males and five females in one portion of a study and 32.9% of intake by nine females in another portion of a study (18) . These values are not remarkably different from those reported by Saarinen et al. (17) for 6-to 7-mo-old breast-fed infants.
In our study, arithmetic mean erythrocyte incorporation of the j8Fe label given with a small dose of iron 2 h after a formula feeding was 6.9% of intake. Assuming that, at 56 d of age, 65% of absorbed iron is promptly incorporated into erythrocytes, iron absorption was 10.6% of intake. This estimate of absorption is less than the 19.5% of the dose reported by Saarinen et al. (17) to be absorbed by 6-to 7-mo-old infants given a small dose of 59Fe 3 h after a formula feeding. However, 6-to 7-mo-old infants would be expected to empty the stomach more rapidly than 2-mo-old infants (19) , and more of the formula feeding would be expected to have left the stomach in 3 h than in 2 h. 
* % Incorp, percentage of "Fe label incorporated into erythrocytes.
milk contains calcium, caseins, and whey proteins that are potent inhibitors of iron absorption (20) (21) (22) (23) (24) (25) (26) (27) (28) . The greater incorporation of iron into erythrocytes by 2-moold breast-fed than by 2-mo-old formula-fed infants in our study, and, in the study by Saarinen er al. (17) , the greater iron absorption by 6-to 7-mo-old breast-fed infants than by formula-fed infants of similar age are probably explained primarily by the lesser quantities of inhibitors of iron absorption in human milk than in infant formulas.
In the breast-fed infants, but not in the formula-fed infants, the amount of the administered 58Fe label incorporated into erythrocytes was significantly greater 56 d after the test feedings in the formula-fed infants. Geometric mean erythrocyte incorporation of the administered 58Fe (6.9% of intake) in the 2-moold infants did not differ greatly from the geometric mean value of 7.9% of intake by 126-d-old formula-fed infants studied previously (5) . However, only nine infants were included in the earlier study, and the quantity of iron given in the test doses was 1.95 mg rather than the 0.6 to l .O mg given in the present study.
Based on the extent of erythrocyte incorporation of small doses of "Fe, the data presented in this report do not support the widely held belief that iron absorption and utilization are extremely low during the first 2 mo of life.
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